Lataa...
Surf early to higher tides: surfactant therapy to optimize tidal volume, lung recruitment, and iNO response
Inhaled nitric oxide is approved by FDA for the management of hypoxemic respiratory failure in term and near-term infants. However, approximately a third of patients treated with inhaled nitric oxide fail to have a sustained improvement in oxygenation. Recruitment of the lung with surfactant enables...
Tallennettuna:
| Julkaisussa: | J Perinatol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220734/ https://ncbi.nlm.nih.gov/pubmed/32792634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41372-020-0764-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|